# Integris Bioservices LLC – FDA Inspection, Oct 20, 2023

Source: https://www.keypedia.com/records/fda_inspections/integris-bioservices-llc/85a3a6fd-39d0-413d-995b-2131a27aee79
Source feed: FDA_Inspections

> FDA inspection 1223662 of Integris Bioservices LLC, October 20, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223662
- Company Name: Integris Bioservices LLC
- Inspection Date: 2023-10-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1279931 - 2025-08-29](https://www.keypedia.com/records/fda_inspections/integris-bioservices-llc/39e76d1a-949e-4ce8-a85f-df88ae062acd)
- FDA Inspection 1102782 - 2019-06-13

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/yiyue-c-zhang/bb9e053e-ff20-4724-b4dc-1ee2e8f23833)

Company: https://www.keypedia.com/companies/integris-bioservices-llc/1f2e0885-338c-49d4-9afd-14924079d628

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
